← FDA DRUG APPROVALS

FDA NDA · NDA021832

LEVOFLOXACIN

Sponsor: SICOR PHARMS

APPLICATION
NDA021832
TYPE
NDA
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
None (Tentative Approval)

Products

LEVOFLOXACINNone (Tentative Approval)
LEVOFLOXACIN 5MG/ML, SODIUM CHLORIDE · INJECTABLE · INJECTION

Approval history

2005-06-20Type 3 - New Dosage Form · Original · standardLetterTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →